Changes in the Relationship Between Gray Matter, Functional Parameters, and Quality of Life in Patients with a Post-Stroke Spastic Upper Limb After Single-Event Multilevel Surgery: Six-Month Results from a Randomized Trial.
TL;DR
The structural analysis of gray matter by MRI revealed differences in patients with post-stroke sequelae undergoing different therapies, suggesting a neuroprotective or regenerative effect of upper limb surgery.
OpenAlex 토픽 ·
Stroke Rehabilitation and Recovery
Botulinum Toxin and Related Neurological Disorders
Cerebral Palsy and Movement Disorders
The structural analysis of gray matter by MRI revealed differences in patients with post-stroke sequelae undergoing different therapies, suggesting a neuroprotective or regenerative effect of upper li
APA
Patricia Hurtado‐Olmo, Pedro Hernández-Cortés, et al. (2025). Changes in the Relationship Between Gray Matter, Functional Parameters, and Quality of Life in Patients with a Post-Stroke Spastic Upper Limb After Single-Event Multilevel Surgery: Six-Month Results from a Randomized Trial.. Diagnostics (Basel, Switzerland), 15(8). https://doi.org/10.3390/diagnostics15081020
MLA
Patricia Hurtado‐Olmo, et al.. "Changes in the Relationship Between Gray Matter, Functional Parameters, and Quality of Life in Patients with a Post-Stroke Spastic Upper Limb After Single-Event Multilevel Surgery: Six-Month Results from a Randomized Trial.." Diagnostics (Basel, Switzerland), vol. 15, no. 8, 2025.
PMID
40310412
Abstract
Advanced magnetic resonance imaging (MRI) techniques in neuroplasticity evaluations provide important information on stroke disease and the underlying mechanisms of neuronal recovery. It has been observed that gray matter density or volume in brain regions closely related to motor function can be a valuable indicator of the response to treatment. : To compare structural MRI-evaluated gray matter volume changes in patients with post-stroke upper limb spasticity for >1 year between those undergoing surgery and those treated with botulinum toxin A (BoNT-A) and to relate these findings to upper limb function and quality of life outcomes. : A two-arm controlled and randomized clinical trial in patients with post-stroke upper limb spasticity. . Thirty post-stroke patients with spastic upper limbs. Participants were randomly assigned (1:1 allocation ratio) for surgery (experimental group) or treatment with BoNT-A (control group). . The functional parameters were analyzed with Fugl-Meyer, Zancolli, Keenan, House, Ashworth, pain visual analogue, and hospital anxiety and depression scales. Quality of life was evaluated using SF-36 and Newcastle stroke-specific quality of life scales. The carer burden questionnaire was also applied. Clinical examinations and MRI scans were performed at baseline and at six months post-intervention. Correlations between brain volume/thickness and predictors of interest were examined across evaluations and groups. : Five patients were excluded due to the presence of intracranial implants. Eleven patients were excluded from analyses since they were late dropouts. Changes were observed in the experimental group but not in the control group. Between baseline and six months, gray matter volume was augmented at the hippocampus and gyrus rectus and cortical thickness was increased at the frontal pole, occipital gyrus, and insular cortex, indicating anatomical changes in key areas related to motor and behavioral adaptation These changes were significantly related to subjective pain, Ashworth spasticity scale, and Newcastle quality of life scores, and marginally related to the carer burden score. : The structural analysis of gray matter by MRI revealed differences in patients with post-stroke sequelae undergoing different therapies. Gray matter volume and cortical thickness measurements showed significant improvements in the surgery group but not in the BoNT-A group. Volume was increased in areas associated with motor and sensory functions, suggesting a neuroprotective or regenerative effect of upper limb surgery.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | Upper Limb
|
scispacy | 1 | ||
| 해부 | neuronal
|
scispacy | 1 | ||
| 해부 | brain
|
scispacy | 1 | ||
| 해부 | upper limbs
|
scispacy | 1 | ||
| 해부 | cortical
|
scispacy | 1 | ||
| 합병증 | brain volume/thickness
|
scispacy | 1 | ||
| 합병증 | intracranial
|
scispacy | 1 | ||
| 합병증 | gyrus rectus
|
scispacy | 1 | ||
| 질환 | Post-Stroke Spastic
|
scispacy | 1 | ||
| 질환 | stroke disease
|
scispacy | 1 | ||
| 질환 | post-stroke
|
scispacy | 1 | ||
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | spastic
|
C0443306
Spastic
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | anxiety
|
C0003467
Anxiety
|
scispacy | 1 | |
| 질환 | depression
|
C0011570
Mental Depression
|
scispacy | 1 | |
| 질환 | post-stroke sequelae
|
scispacy | 1 | ||
| 질환 | insular cortex
|
scispacy | 1 | ||
| 기타 | Post-Stroke
|
scispacy | 1 | ||
| 기타 | botulinum toxin A
|
scispacy | 1 | ||
| 기타 | BoNT-A
→ botulinum toxin A
|
scispacy | 1 | ||
| 기타 | Participants
|
scispacy | 1 | ||
| 기타 | Fugl-Meyer
|
scispacy | 1 | ||
| 기타 | occipital gyrus
|
scispacy | 1 | ||
| 기타 | Newcastle
|
scispacy | 1 | ||
| 기타 | cortical
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (2)
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.